CareDx, Inc.: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Aug 9, 2018 and accepted by EDGAR at Aug 9, 2018, 17:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-04-01 to 2018-06-30 | $17.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2018-01-01 to 2018-06-30 | $31.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2018-04-01 to 2018-06-30 | $3.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-01-01 to 2018-06-30 | $6.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-04-01 to 2018-06-30 | −$5.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-01-01 to 2018-06-30 | −$10.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2018-04-01 to 2018-06-30 | −$381.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-01-01 to 2018-06-30 | −$805.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-04-01 to 2018-06-30 | −$14.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-01-01 to 2018-06-30 | −$23.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-04-01 to 2018-06-30 | −$0.40 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2018-01-01 to 2018-06-30 | −$0.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-04-01 to 2018-06-30 | −$0.40 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2018-01-01 to 2018-06-30 | −$0.71 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-04-01 to 2018-06-30 | 35,549,837 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2018-01-01 to 2018-06-30 | 32,599,032 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2018-01-01 to 2018-06-30 | −$6.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-01-01 to 2018-06-30 | $461.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2018-01-01 to 2018-06-30 | $142.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-06-30 | $16.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-06-30 | $30.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $79.9m | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $14.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-06-30 | $50.9m | us-gaap:Liabilities |
| Long-term debt | At period end2018-06-30 | $13.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2018-06-30 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2018-06-30 | $29.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-18-021123. Last ingested by Listed: Nov 13, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.